To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

The European medical info… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




The European medical information framework: A novel ecosystem for sharing healthcare data across Europe

Journal article
Authors S. Lovestone
B. Vannieuwenhuyse
P. J. Visser
I. Bos
S. Vos
J. Streffer
Ulf Smith
D. Waterworth
J. van der Lei
P. Rijnbeek
J. L. Oliveira
M. Van Speybroeck
R. Verbeeck
D. Kalra
N. Lea
E. Molero
M. Lewi
M. Alexander
G. James
C. Sage
J. Praet
P. Egger
G. Singh
N. Hughes
Published in Learning Health Systems
Volume 4
Issue 2
Pages e10214
ISSN 2379-6146
Publication year 2019
Published at Institute of Medicine, Department of Molecular and Clinical Medicine
Pages e10214
Language en
Links dx.doi.org/10.1002/lrh2.10214
Keywords catalogue, EMIF, EMIF-AD, EMIF-MET, use case, mild cognitive impairment, fatty liver-disease, translational research, clinical-research, prevalence, dementia, biomarkers, databases, platform, support, Health Care Sciences & Services
Subject categories Health Care Service and Management, Health Policy and Services and Health Economy

Abstract

Introduction The European medical information framework (EMIF) was an Innovative Medicines Initiative project jointly supported by the European Union and the European Federation of Pharmaceutical Industries and Associations, that generated a common technology and governance framework to identify, assess and (re)use healthcare data, to facilitate real-world data research. The objectives of EMIF included providing a unified platform to support a wide range of studies within two verification programmes-Alzheimer's disease (EMIF-AD), and metabolic consequences of obesity (EMIF-MET). Methods The EMIF platform was built around two main data-types: electronic health record data and research cohort data, and the platform architecture composed of a set of tools designed to enable data discovery and characterisation. This included the EMIF catalogue, which allowed users to find relevant data sources, including the data-types collected. Data harmonisation via a common data model were central to the project especially for population data sources. EMIF also developed an ethical code of practice to ensure data protection, patient confidentiality and compliance with the European Data Protection Directive, and GDPR. Results Currently 18 population-based disease agnostic and 60 cohort-based Alzheimer's data partners from across 14 countries are contained within the catalogue, and this will continue to expand. The work conducted in EMIF-AD and EMIF-MET includes standardizing cohorts, summarising baseline characteristics of patients, developing diagnostic algorithms, epidemiological studies, identifying and validating novel biomarkers and selecting potential patient samples for pharmacological intervention. Conclusions EMIF was designed to provide a sustainable model as demonstrated by the sustainability plans for EMIF-AD. Although network-wide studies using EMIF were not conducted during this project to evaluate its sustainability, learning from EMIF will be used in the follow-on IMI-2 project, European Health Data and Evidence Network (EHDEN). Furthermore, EMIF has facilitated collaborations between partners and continues to promote a wider adoption of principles, technology and architecture through some of its continued work.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?